10/23/2012 03:25 EDT | Updated 12/23/2012 05:12 EST

Nova Scotia to expand vision loss treatment program to Cape Breton

SYDNEY, N.S. - The Nova Scotia government is expanding its treatment for a chronic retina disease that leads to vision loss.

Premier Darrell Dexter says the province's Lucentis and Avastin treatments for wet macular degeneration will be offered by the Cape Breton District Health Authority beginning early next month.

The move will save patients from travelling to Halifax for treatment.

The treatments will be available at the Glace Bay Hospital eye clinic once ophthalmologists in the district have been trained to provide the injections and diagnostic equipment has been updated to new standards.

Wet macular degeneration is a condition that can lead to blood and fluid leak into the eye causing blindness in people 50-years of age or older.

The province has funded the therapies through its Pharmacare program since January 2011.